HEGGIE THERESA (CIK 1760020) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-15). Recent activity: Buy BCRX (15,294 shares), Buy BCRX (49,933 shares), Sell BCRX (49,933 shares), Buy BCRX (30,000 shares), Buy BCRX (40,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 15,294 | $0 |
| 2026-03-24 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 49,933 | $314,578 |
| 2026-03-24 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Sell | 49,933 | $504,823 |
| 2025-08-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 30,000 | $87,300 |
| 2025-08-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 40,000 | $216,400 |
| 2025-08-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Sell | 70,000 | $595,700 |
| 2025-06-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 12,500 | $0 |
Source: SEC Form 4 filings · as of 2026-06-15